MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

PHASE4CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Rosacea

Interventions

DRUG

Brimonidine 0.33% gel (Br)

OTHER

CD07805/47 (Br) placebo gel

DRUG

Ivermectin 1% cream (IVM)

OTHER

CD5024 (IVM) placebo cream

Trial Locations (13)

Fort Smith

Rogers

Sacramento

Orlando

Omaha

New York

Pflugerville

Surrey

Markham

Peterborough

Richmond Hill

Waterloo

Windsor